Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Shanrong Biotechnology Corp | 179.4K | 0.0x | --- |
Worldwide Holdings Delaware Corp | 550.0 | 0.0x | --- |
Nextmart Inc | 220.8K | 0.0x | --- |
Xenonics Holdings Inc | 30.0 | 0.0x | --- |
Safeplus International Holdings Ltd | 3.2K | 0.0x | --- |
RegenETP, Inc | 515.6K | -0.1x | --- |
Shanrong Biotechnology Corp. is a holding company for select biotechnology, health, and wellness operations. The Company owns and operates three patents: Long-lasting preparation of long-term stable intravenous melatonin injectable addressing sepsis, bacterial pathologies, and other inflammatory pathology; new melatonin formulations for the treatment of chemotherapy-resistant tumors addressing cancer (head and neck, prostate, breast, ovarian, melanoma) and injectable melatonin composition for the treatment of viral diseases addressing COVID-19 and other viral diseases.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $179.4K |
---|---|
Revenue (TTM) | $1.3M |
Shares Outstanding | 484.9K |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -3.38 |
EPS | $-15.40 |
Book Value | $-11.40 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 0.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -362.96% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.